Eric Hardter

Eric Hardter, Ph.D., RAC, is a motivated regulatory affairs professional currently serving as the Director of Regulatory Affairs at Boyds. With over eight years of regulatory experience and four years in leadership roles, they have a proven track record in managing both teams and projects while developing tailored regulatory strategies across various investigational products and therapeutic areas. Eric's expertise spans small molecules, biologics, and cell and gene therapies, and includes extensive experience with clinical trial protocols and submissions. They have previously held positions at Emmes and Technical Resources International, Inc., and have contributed to business development and educational initiatives throughout their career.